Preventable Hospitalization in Dementia: The Impact of Neuropsychiatric Symptoms

痴呆症可预防的住院治疗:神经精神症状的影响

基本信息

  • 批准号:
    8769634
  • 负责人:
  • 金额:
    $ 17.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-15 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Older adults with dementia are at increased risk of hospitalization when compared to adults without dementia of similar age and medical comorbidity. The increased risk of hospitalization extends to potentially preventable hospitalization (PPH) for conditions such as a urinary tract infection or asthma exacerbation, suggesting difficulty in outpatient management of patients with dementia. Neuropsychiatric symptoms (NPS) of dementia such as agitation or delusions likely account for a significant amount of this risk, given their prevalence and potential to cause caregiver distress. While there are effective interventions for patients and caregivers to reduce NPS, the profile of patients that could benefit the most from intervention, therefore reducing their hospitalization risk, is unknown. Through the coordinated program of mentorship, didactics, and research that I propose, I will develop the advanced skills to derive and apply administrative, claims, and clinical encounter data to prospectively identify those patients with dementia at highest risk for hospitalization. Development of this patient-level risk phenotype means that future interventions to reduce hospitalization can then be prospectively matched to the patients most likely to benefit, a development of critical public health importance given both financial and geriatric work force constraints. Over the next four years, my short-term training goals include: (1) address gaps in my formal research training, specifically: (a) to conduct observational analyses using large-scale claims and administrative data; (b) to derive clinical data from the electronic health record using natural language processing; and (c) to apply advanced methods of data analysis for risk prediction; (2) train in presentations, manuscript writing, and grantsmanship that culminate with a R01 proposal; (3) establish further connections with potential collaborators in the University of Michigan (UM) Pepper Center and broader community of aging researchers, national geriatrics and geriatric psychiatry communities, and the Beeson Scholar community; and (4) engage in leadership development with an emphasis on skills to lead a research team, mentor junior investigators, and communicate findings in research and clinical care settings. These short-term goals will be paired with research aims that focus on elaborating the PPH risk profile for patients with dementia. Such research objectives can only be achieved when: (1) full clinical characteristics are available for the at-risk (i.e., non-hospitalized) population, includig (2) NPS data, which are rarely captured in standard administrative claims data. These criteria are uniquely met in the Veterans Affairs healthcare system, which has one of the nation's most advanced electronic health records (EHR). Using a national dementia case repository (N=269,565) from which I will draw matched cases (patients with dementia + PPH) and controls (non-hospitalized patients with dementia). Aim 1 will use claims and administrative data to explore patient, treatment, and facility risk factors associated with PPH. Aim 2 will use natural language processing to derive NPS from EHR clinical encounter notes and then characterize the association of NPS with PPH. Using the risk phenotype described in Aims 1 and 2, Aim 3 will develop logistic risk-prediction models to prospectively identify patients with dementia at highest risk for PPH. In subsequent grant proposals I will validate this risk- prediction model in other healthcare systems and prospectively pair the assessment tool with an evidence- based dementia intervention to reduce hospitalization. My long-term career goals are to: (1) establish myself as independent investigator and national leader in geriatric mental health services research; (2) develop a programmatic line of funded health services research that develops risk-stratification models for late-life mental health and cognitive disorders; (3) translate knowledge from these research endeavors to improve the targeting and impact of future interventions research and health system delivery strategies; and (4) contribute broadly to the care of older adults by training and mentoring future clinical researchers in late-life mental health disorders. I am an Assistant Professor and geriatric psychiatrist at the University of Michigan, where I am also currently completing a MSc in Health and Healthcare Research, which provides an excellent background in health services research for clinicians. With this combination of clinical expertise and foundational training in health services research, I am uniquely qualified to undertake the advanced training activities outlined in this proposal, while UM affords the ideal environment in which to pursue this work. My primary mentor (Helen Kales, MD) and co-mentor (Frederic Blow, PhD) are national leaders in geriatric mental health who have used observational data to answer questions of national significance. My Advisory Panel includes Constantine Lyketsos, MD, MHS, an internationally-recognized expert in NPS and dementia care, and Kenneth Langa, MD, PhD, an internist, former Beeson Scholar, and renowned expert in using survey and secondary data to inform our understanding of dementia. Consultants include David Hanauer, MD, MS, an expert in bioinformatics and natural language processing, and Rodney Hayward, MD, a leader in risk assessment and intervention- targeting. My advisory team paired with resources of Michigan's Pepper Center, CTSA, and multi-disciplinary Institute for Healthcare Policy and Innovation make this the ideal environment in which to complete the proposed training activities.
描述(由申请人提供):与年龄和医学合并症相似的未患痴呆症的成年人相比,患有痴呆症的老年人住院治疗的风险增加。住院风险的增加延伸到潜在可预防的住院(PPH)的条件,如尿路感染或哮喘加重,这表明在痴呆患者的门诊管理的困难。痴呆症的神经精神症状(NPSs),如激动或妄想,可能占这种风险的显着量,因为它们的患病率和可能导致照顾者痛苦。虽然有有效的干预措施,为病人和照顾者,以减少吸毒,病人的概况, 是否能从干预中获益最多,从而降低其住院风险,目前尚不清楚。通过我提出的指导,教学和研究的协调计划,我将开发先进的技能来获取和应用行政,索赔和临床遇到的数据,以前瞻性地确定那些痴呆症患者住院的风险最高。这种患者水平风险表型的发展意味着未来减少住院的干预措施可以前瞻性地与最有可能受益的患者相匹配,考虑到财政和老年工作,这一发展具有关键的公共卫生重要性 力约束。 在接下来的四年里,我的短期培训目标包括:(1)解决我在正式研究培训中的差距,具体来说:(a)使用大规模索赔和行政数据进行观察分析;(B)使用自然语言处理从电子健康记录中获取临床数据;(c)应用先进的数据分析方法进行风险预测;(2)培训演示文稿,手稿写作和最终以R 01提案达到高潮的granitarian;(3)与密歇根大学(UM)Pepper中心和更广泛的老龄化研究人员社区,国家老年医学和老年精神病学社区以及Beeson Scholar社区的潜在合作者建立进一步的联系;以及(4)参与领导力发展,重点是领导研究团队的技能,指导初级研究人员,并在研究和临床护理环境中交流研究结果。 这些短期目标将与研究目标相结合,重点是阐述痴呆患者的PPH风险状况。只有在以下情况下才能实现此类研究目标:(1)有风险的患者具有完整的临床特征(即,非住院)人群,包括(2)标准行政索赔数据中很少记录的非住院数据。这些标准在退伍军人事务部医疗保健系统中得到了独特的满足,该系统拥有全国最先进的电子健康记录(EHR)之一。使用国家痴呆症病例库(N= 269,565),我将从中抽取匹配的病例(痴呆症+ PPH患者)和对照组(非住院痴呆症患者)。目标1将使用索赔和管理数据来探索与PPH相关的患者,治疗和设施风险因素。目标2将使用自然语言处理从EHR临床就诊记录中获得患者信息,然后描述患者信息与PPH的关联。使用目标1和2中描述的风险表型,目标3将开发逻辑风险预测模型,以前瞻性地识别PPH风险最高的痴呆患者。在随后的拨款申请中,我将在其他医疗保健系统中验证这种风险预测模型,并前瞻性地将评估工具与基于证据的痴呆症干预措施配对,以减少住院治疗。 我的长期职业目标是:(1)建立自己作为独立的调查员和老年心理健康服务研究的国家领导人;(2)开发资助的卫生服务研究的程序线,开发晚年心理健康和认知障碍的风险分层模型;(3)将这些研究工作的知识转化为改进未来干预研究和卫生系统交付战略的目标和影响;以及(4)通过培训和指导未来的老年精神健康障碍临床研究人员,为老年人的护理做出广泛贡献。我是密歇根大学的助理教授和老年精神病学家,我目前正在完成健康与医疗保健研究硕士学位,这为临床医生提供了健康服务研究的优秀背景。有了临床专业知识和卫生服务研究基础培训的这种结合,我唯一有资格承担本提案中概述的高级培训活动,而UM提供了理想的环境来从事这项工作。我的主要导师(Helen Kales,医学博士)和共同导师(Frederic Blow,博士)是老年心理健康领域的国家领导人,他们使用观察数据来回答具有国家意义的问题。我的顾问小组包括Constantine Lyketsos,医学博士,MHS,一位国际公认的痴呆症和痴呆症护理专家,以及Kenneth朗加,医学博士,博士,内科医生,前Beeson Scholar,以及使用调查和二手数据来告知我们对痴呆症的理解的著名专家。顾问包括生物信息学和自然语言处理专家大卫哈瑙尔,医学博士,理学硕士,以及风险评估和干预目标的领导者罗德尼海沃德,医学博士。我的咨询团队与密歇根州胡椒中心、CTSA和多学科医疗保健政策与创新研究所的资源相结合,使这里成为完成拟议培训活动的理想环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONOVAN T MAUST其他文献

DONOVAN T MAUST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONOVAN T MAUST', 18)}}的其他基金

The Impact of Alzheimer’s Disease and Related Dementias on Nursing Home Care and Quality for Persons with Serious Mental Illness
阿尔茨海默病和相关痴呆症对严重精神疾病患者的疗养院护理和质量的影响
  • 批准号:
    10803736
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
The National Dementia Workforce Study
国家痴呆症劳动力研究
  • 批准号:
    10774551
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10774552
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia
在没有指导的情况下开药:一项关于痴呆症患者精神药物和阿片类药物复方用药的全国研究
  • 批准号:
    10337351
  • 财政年份:
    2022
  • 资助金额:
    $ 17.51万
  • 项目类别:
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia
在没有指导的情况下开药:一项关于痴呆症患者精神药物和阿片类药物复方用药的全国研究
  • 批准号:
    10608057
  • 财政年份:
    2022
  • 资助金额:
    $ 17.51万
  • 项目类别:
Addressing inappropriate benzodiazepine prescribing among older Veterans
解决老年退伍军人中不当使用苯二氮卓类药物的问题
  • 批准号:
    9653887
  • 财政年份:
    2018
  • 资助金额:
    $ 17.51万
  • 项目类别:
Addressing inappropriate benzodiazepine prescribing among older Veterans
解决老年退伍军人中不当使用苯二氮卓类药物的问题
  • 批准号:
    10186531
  • 财政年份:
    2018
  • 资助金额:
    $ 17.51万
  • 项目类别:
Patient, Caregiver, and Regional Drivers of Potentially Inappropriate Medical Care for Dementia: Building the Foundation for State Dementia Policy
痴呆症医疗护理可能不适当的患者、护理人员和地区驱动因素:为国家痴呆症政策奠定基础
  • 批准号:
    10090545
  • 财政年份:
    2018
  • 资助金额:
    $ 17.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了